These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 21780227)

  • 1. Diagnosis of colorectal hepatic metastases: comparison of contrast-enhanced CT, contrast-enhanced US, superparamagnetic iron oxide-enhanced MRI, and gadoxetic acid-enhanced MRI.
    Muhi A; Ichikawa T; Motosugi U; Sou H; Nakajima H; Sano K; Sano M; Kato S; Kitamura T; Fatima Z; Fukushima K; Iino H; Mori Y; Fujii H; Araki T
    J Magn Reson Imaging; 2011 Aug; 34(2):326-35. PubMed ID: 21780227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hepatic and hepatocarcinoma magnetic resonance: comparison of the results obtained with paramagnetic (gadolinium) and superparamagnetic (iron oxide particles) contrast media].
    Castoldi MC; Fauda V; Scaramuzza D; Vergnaghi D
    Radiol Med; 2000 Sep; 100(3):160-7. PubMed ID: 11148882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of biphasic spiral CT, conventional and iron oxide enhanced MRI on therapy and therapy costs in patients with focal liver lesions].
    Helmberger T; Gregor M; Holzknecht N; Rau H; Scheidler J; Reiser M
    Rofo; 2000 Mar; 172(3):251-9. PubMed ID: 10778456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual contrast enhanced magnetic resonance imaging of the liver with superparamagnetic iron oxide followed by gadolinium for lesion detection and characterization.
    Kubaska S; Sahani DV; Saini S; Hahn PF; Halpern E
    Clin Radiol; 2001 May; 56(5):410-5. PubMed ID: 11384141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of hepatic metastases: comparison of contrast-enhanced CT, unenhanced MR imaging, and iron oxide-enhanced MR imaging.
    Fretz CJ; Stark DD; Metz CE; Elizondo G; Weissleder R; Shen JH; Wittenberg J; Simeone J; Ferrucci JT
    AJR Am J Roentgenol; 1990 Oct; 155(4):763-70. PubMed ID: 2119106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Benign hepatic tumors: MRI features before and after administration of superparamagnetic contrast media].
    Bartolotta TV; Midiri M; Galia M; Carcione A; De Maria M; Lagalla R
    Radiol Med; 2001 Apr; 101(4):219-29. PubMed ID: 11398050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic lesion detection: comparison of MR imaging after the administration of superparamagnetic iron oxide with dual-phase CT by using alternative-free response receiver operating characteristic analysis.
    Ward J; Naik KS; Guthrie JA; Wilson D; Robinson PJ
    Radiology; 1999 Feb; 210(2):459-66. PubMed ID: 10207430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic lesion detection after superparamagnetic iron oxide enhancement: comparison of five T2-weighted sequences at 1.0 T by using alternative-free response receiver operating characteristic analysis.
    Ward J; Chen F; Guthrie JA; Wilson D; Lodge JP; Wyatt JI; Robinson PJ
    Radiology; 2000 Jan; 214(1):159-66. PubMed ID: 10644117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colorectal hepatic metastases: detection with SPIO-enhanced breath-hold MR imaging--comparison of optimized sequences.
    Ward J; Guthrie JA; Wilson D; Arnold P; Lodge JP; Toogood GJ; Wyatt JI; Robinson PJ
    Radiology; 2003 Sep; 228(3):709-18. PubMed ID: 12888620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of SPIO-MR imaging in the diagnosis of liver metastases from colorectal carcinomas.
    Furuhata T; Okita K; Tsuruma T; Hata F; Kimura Y; Katsuramaki T; Mukaiya M; Hirokawa N; Ichimura T; Yama N; Koito K; Sasaki K; Hirata K
    Dig Surg; 2003; 20(4):321-5. PubMed ID: 12806198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of liver metastases: comparison of superparamagnetic iron oxide-enhanced and unenhanced MR imaging at 1.5 T with dynamic CT, intraoperative US, and percutaneous US.
    Hagspiel KD; Neidl KF; Eichenberger AC; Weder W; Marincek B
    Radiology; 1995 Aug; 196(2):471-8. PubMed ID: 7617863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Usefulness of superparamagnetic iron oxide particle (AMI-25) enhanced MR imaging for the diagnosis of liver tumors: comparison with contrast enhanced CT].
    Hirohashi S; Hirohashi R; Uchida H; Kachi K; Ohtomo K; Uchiyama G; Niitsu M; Itai Y
    Nihon Igaku Hoshasen Gakkai Zasshi; 1994 Jul; 54(8):776-83. PubMed ID: 8072868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of the diagnostic efficacy of SPIO enhanced MRI in patients with focal hepatic lesions--comparison with CECT and CTAP].
    Kasugai H; Katayama N; Sakai S; Yamakawa T
    Gan To Kagaku Ryoho; 2002 Nov; 29(12):2311-5. PubMed ID: 12484062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of Gd-EOB-DTPA and superparamagnetic iron oxide particles in the detection of primary liver cancer: a comparative study by alternative free-response receiver operating characteristic analysis.
    Tanimoto A; Satoh Y; Yuasa Y; Jinzaki M; Hiramatsu K
    J Magn Reson Imaging; 1997; 7(1):120-4. PubMed ID: 9039601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing Sonazoid contrast-enhanced ultrasound to contrast-enhanced CT and MRI for differentially diagnosing renal lesions: a prospective multicenter study.
    Zhao QX; Wu C; Tan S; Yang Y; Cui XW; Dietrich CF; Yang B; Xu CL; Gao YY; Xie MX; Wu CJ; Liu LP; Wang XH; Ling-Hu RZ; Wang N; Wang F; Wang XL; Liu GY; Yu XL; Yu J; Cheng ZG; Liang P
    World J Urol; 2024 May; 42(1):302. PubMed ID: 38720010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [MRI with supermagnetic iron particles versus double-spiral CT in identification of malignant liver lesions].
    Müller RD; Vogel K; Neumann K; Hirche H; Barkhausen J; Stöblen F; Henrich H; Langer R
    Rofo; 1998 May; 168(5):436-43. PubMed ID: 9617359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Detection of liver tumors].
    Rummeny EJ; Reimer P; Daldrup H; Peters PE
    Radiologe; 1995 Nov; 35(11 Suppl 2):S252-8. PubMed ID: 8588031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of focal liver lesions: CT of the hepatobiliary system with gadoxetic acid disodium, or Gd-EOB-DTPA.
    Schmitz SA; Häberle JH; Balzer T; Shamsi K; Boese-Landgraf J; Wolf KJ
    Radiology; 1997 Feb; 202(2):399-405. PubMed ID: 9015065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Magnetic resonance imaging manifestation of 500 patients with primary hepatic cell carcinoma].
    Sun Y; Liang BL; Zhang XH; Shen J; Xie BK
    Ai Zheng; 2002 May; 21(5):509-13. PubMed ID: 12452042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of Sonazoid-enhanced ultrasonography in characterizing indeterminate focal liver lesions on gadoxetic acid-enhanced liver MRI in patients without risk factors for hepatocellular carcinoma.
    Ban JY; Kang TW; Jeong WK; Lee MW; Park B; Song KD
    PLoS One; 2024; 19(5):e0304352. PubMed ID: 38787832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.